Price Chart

Price Chart

Profile

Insight Molecular Diagnostics, Inc. is a diagnostics technology company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The company was founded in September 2009 and is headquartered in Nashville, TN.
URL http://www.imdxinc.com
Investor Relations URL https://investors.imdxinc.com/
HQ State/Province Tennessee
Sector Health Care
Industry Biotechnology
Equity Style Small Cap Growth
Next Earnings Release Nov. 09, 2026 (est.)
Last Earnings Release Aug. 10, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Insight Molecular Diagnostics, Inc. is a diagnostics technology company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The company was founded in September 2009 and is headquartered in Nashville, TN.
URL http://www.imdxinc.com
Investor Relations URL https://investors.imdxinc.com/
HQ State/Province Tennessee
Sector Health Care
Industry Biotechnology
Equity Style Small Cap Growth
Next Earnings Release Nov. 09, 2026 (est.)
Last Earnings Release Aug. 10, 2026
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A